Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
33672 Results Found
AHA Voices Concern with Express Scripts’ New 340B Claims Reporting Policy
Amy Bricker
President
Express Scripts PBM
1 Express Way
Saint Louis, MO 63121
Dear Ms. Bricker:
AHA Leadership
Your AHA leadership team, Board of Trustees and regional executives are working to serve you and the hospital and health system field. Click through for more information.
5 Ways Administrative and Clinical Leaders Can Convene for Value
The COVID-19 pandemic has forever altered the way hospitals and health systems care for patients. Much has been written and said about the pandemic’s devastating effects; there are, however, some silver linings.
Hospital-Led Innovation Efforts Produce Results
Navv Systems Inc., born out of Henry Ford Health System, will use the injection of a $3.2 million venture capital seed round to bolster its pipeline of health care systems focused on better tracking of equipment and personnel, as well as helping patients and visitors better navigate complex facilities.
HRSA awards $125 million to bolster COVID-19 vaccination in underserved areas
The Health Resources and Services Administration awarded 14 organizations grants to hire people to support COVID-19 vaccination and outreach in vulnerable and medically underserved communities.
FDA adds tubes to collect blood specimens to device shortage list
The Food and Drug Administration added sodium citrate tubes used to collect blood specimens to its device shortage list and recommended health care providers only use the tubes when medically necessary, among other conservation strategies.
CMS: Since April, 1 million select marketplace plan for $10 or less per month
More than 1 million Americans selecting a 2021 health plan through the federally facilitated marketplace since April 1 will pay $10 or less per month, the Centers for Medicare & Medicaid Services announced.
Novavax releases first late-trial COVID-19 vaccine data; reports 90.4% efficacy, strong protection against variants
Novavax announced phase 3 trial results for its COVID-19 vaccine, saying it provides 100% protection against moderate and severe disease, with a 90.4% overall efficacy.
FDA authorizes drug substance batches for use in J&J vaccine
The Food and Drug Administration Friday authorized for emergency use two batches of drug substance manufactured for the Janssen (Johnson & Johnson) COVID-19 vaccine at an Emergent BioSolutions facility in Baltimore.
Study Examines Price Differences and Debt-collection Practices of Hospitals
A soon-to-be-released study on hospital debt-collection practices is beginning to receive significant media attention, including an article post